Molecular and in silico analysis of BRCA1 and BRCA2 variants

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 644, Issue 1-2, 2008, Pages 64-70

  Tommasi, Stefania ^a   Pilato, Brunella ^a   Pinto, Rosamaria ^a   Monaco, Alessandro ^a   Bruno, Michele ^a   Campana, Marco ^a   Digennaro, Maria ^a   Schittulli, Francesco ^a   Lacalamita, Rosanna ^a   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

BRCA; Breast cancer risk; Familiarity; In silico analysis; Mutation; Polymorphisms

Indexed keywords

ADULT; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICE SITES; VARIATION (GENETICS);

EID: 49749090418     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.07.005     Document Type: Article

References (23)

1. Yan L., and Beckman R.A. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Biotechniques 39 (2005) 565-568
2. R. Sachidanandam, D. Weissman, S.C. Schmidt, J.M. Kakol, L.D. Stein, G. Marth, S. Sherry, J.C. Mullikin, B.J. Mortimore, D.L. Willey, S.E. Hunt, C.G. Cole, P.C. Coggill, C.M. Rice, Z. Ning, J. Rogers, D.R. Bentley, P.Y. Kwok, E.R. Mardis, R.T. Yeh, B. Schultz, L. Cook, R. Davenport, M. Dante, L. Fulton, L. Hillier, R.H. Waterston, J.D. McPherson, B. Gilman, S. Schaffner, W.J. Van Etten, D. Reich, J. Higgins, M.J. Daly, B. Blumenstiel, J. Baldwin, N. Stange-Thomann, M.C. Zody, L. Linton, E.S. Lander, D. Altshuler, International SNP Map Working Group: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms, Nature 409 (2001) 928-933.
3. Efferth T., and Volm M. Pharmacogenetics for individualized cancer chemotherapy. Pharmacol. Ther. 107 (2005) 155-176
4. Dubey S., Stephenson P., Levy D.E., Miller J.A., Keller S.M., Schiller J.H., Johnson D.H., Kolesar J.M., and Eastern Cooperative Oncology Group. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. J. Thorac. Oncol. 1 (2006) 406-412
5. Tommasi S., Crapolicchio A., Lacalamita R., Bruno M., Monaco A., Petroni S., Schittulli F., Longo S., Digennaro M., Calistri D., Mangia A., and Paradiso A. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mut. Res. 578 (2005) 395-405
6. Chen X., Truong T.T., Weaver J., Bove B.A., Cattie K., Armstrong B.A., Daly M.B., and Godwin A.K. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum. Mut. 27 (2006) 427-435
7. Tommasi S., Fedele V., Lacalamita R., Bruno M., Schittulli F., Ginzinger D., Scott G., Eppenberger-Castori S., Calistri D., Casadei S.S., Seymour I., Longo S., Giannelli G., Pilato B., Simone G., Benz C.C., and Paradiso A. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. Cell. Oncol. 29 (2007) 241-248
8. Frank T.S., Manley S.A., Olopade O.I., Cummings S., Garber J.E., Bernhardt B., Antman K., Russo D., Wood M.E., Mullineau L., Isaacs C., Peshkin B., Buys S., Venne V., Rowley P.T., Loader S., Offit K., Robson M., Hampel H., Brener D., Winer E.P., Clark S., Weber B., Strong L.C., Thomas A., et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16 (1998) 2417-2425
9. Reese M.G., Eeckman F.H., Kulp D., and Haussler D. Improved splice site detection in genie. J. Comp. Biol. 4 (1997) 311-323
10. Ng P.C., and Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31 (2003) 3812-3814
11. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30 (2002) 3894-3900
12. Yuan H.Y., Chiou J.J., Tseng W.H., Liu C.H., Liu C.K., Lin Y.J., Wang H.H., Yao A., Chen Y.T., and Hsu C.N. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34 (2006) W635-W641
13. Pesole G., and Liuni S. Internet resources for the functional analysis of 5′ and 3′ untranslated regions of eukaryotic mRNA. Trends Genet. 15 (1999) 378
14. Giannini G., Capalbo C., Ristori E., Ricevuto E., Sidoni T., Buffone A., Cortesi E., Marchetti P., Scambia G., Tomao S., Rinaldi C., Zani M., Ferraro S., Frati L., Screpanti I., and Gulino A. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Breast Cancer Res. Treat. 100 (2006) 83-91
15. Vasickova P., Machackova E., Lukesova M., Damborsky J., Horky O., Pavlu H., Kuklova J., Kosinova V., Navratilova M., and Foretova L. High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. Med. Genet. 8 (2007) 32
16. D.F. Easton, K.A. Pooley, A.M. Dunning, P.D. Pharoah, D. Thompson, D.G. Ballinger, J.P. Struewing, J. Morrison, H. Field, R. Luben, N. Wareham, S. Ahmed, C.S. Healey, R. Bowman, SEARCH collaborators, K.B. Meyer, C.A. Haiman, K.H. Kolonel, B.E. Henderson, L. Le Marchand, P. Brennan, S. Sangrajrang, V. Gaborieau, F. Odefrey, C.Y. Shen, P.E. Wu, H.C. Wang, D. Eccles, D.G. Evans, J. Peto, O. Fletcher, N. Johnson, S. Seal, M.R. Stratton, N. Rahman, G. Chenevix-Trench, S.E. Bojesen, B.G. Nordestgaard, C.K. Axelsson, M. Garcia-Closas, L. Brinton, S. Chanock, J. Lissowska, B. Peplonska, H. Nevanlinna, R. Fagerholm, H. Eerola, D. Kang, K.Y. Yoo, D.Y. Noh, S.H. Ahn, D.J. Hunter, S.E. Hankinson, D.G. Cox, P. Hall, S. Wedren, J. Liu, Y.L. Low, N. Bogdanova, P. Schürmann, T. Dörk, R.A. Tollenaar, C.E. Jacobi, P. Devilee, J.G. Klijn, A.J. Sigurdson, M.M. Doody, B.H. Alexander, J. Zhang, A. Cox, I.W. Brock, G. MacPherson, M.W. Reed, F.J. Couch, E.L. Goode, J.E. Olson, H. Meijers-Heijboer, A. van den Ouweland, A. Uitterlinden, F. Rivadeneira, R.L. Milne, G. Ribas, A. Gonzalez-Neira, J. Benitez, J.L. Hopper, M. McCredie, M. Southey, G.G. Giles, C. Schroen, C. Justenhoven, H. Brauch, U. Hamann, Y.D. Ko, A.B. Spurdle, J. Beesley, X. Chen, kConFab, AOCS Management Group, A. Mannermaa, V.M. Kosma, V. Kataja, J. Hartikainen, N.E. Day, D.R. Cox, B.A. Ponder, Genome-wide association study identifies novel breast cancer susceptibility loci, Nature 447 (2007) 1087-1093.
17. Janezic S.A., Ziogas A., Krumroy L.M., Krasner M., Plummer S.J., Cohen P., Gildea M., Barker D., Haile R., Casey G., and Anton-Culver H. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Hum. Mol. Genet. 5 (1999) 889-897
18. Sigurdson A.J., Hauptmann M., Chatterjee N., Alexander B.H., Doody M.M., Rutter J.L., and Struewing J.P. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 4 (2004) 9
19. Welcsh P.L., and King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10 (2001) 705-713
20. Wenham R.M., Schildkraut J.M., McLean K., Calingaert B., Bentley R.C., Marks J., and Berchuck A. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. Clin. Cancer Res. 9 (2003) 4396-4403
21. Healey C.S., Dunning A.M., Teare M.D., Chase D., Parker L., Burn J., Chang-Claude J., Mannermaa A., Kataja V., Huntsman D.G., Pharoah P.D., Luben R.N., Easton D.F., and Ponder B. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat. Genet. 26 (2000) 362-364
22. Seymour I.J., Casadei S., Zampiga V., Rosato S., Danesi R., Falcini F., Strada M., Morini N., Naldoni C., Paradiso A., Tommasi S., Schittulli F., Amadori D., and Calistri D. Disease family history and modification of breast cancer risk in common BRCA2 variants. Oncol. Rep. 19 (2008) 783-786
23. Bonatti F., Pepe C., Tancredi M., Lombardi G., Aretini P., Sensi E., Falaschi E., Cipollini G., Bevilacqua G., and Caligo M.A. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Cancer Genet. Cytogenet. 170 (2006) 93-101